| 标题 |
LBA13 Nivolumab and ipilimumab in early-stage triple negative breast cancer (TNBC) with tumor-infiltrating lymphocytes (TILs): First results from the BELLINI trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:I. Nederlof; O. Isaeva; N. Bakker; M. de Graaf; R. Salgado; et al 出版日期:2022-09-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)